74 results
Page 4 of 4
6-K
EX-99.2
onnmuk2g5cg
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
EX-99.1
iiwhw1 im
6 Dec 18
Therapix Biosciences Reports Third
6:18am
6-K
EX-99.1
xiyx3 ujpyf4v1im3
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
6-K
EX-10.3
7f03 jpur
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
khq3gl 77pn79c
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-10.1
ihilzt8ee8ewqf mf
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-10.2
pj8og2lyakmrdqla mj
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-99.1
mqb72wxh 1aje2nhfy
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-99.1
wbuc8ey31iroq21j tsf
24 Oct 18
Report of Foreign Private Issuer
6:45am
CORRESP
37n6rm44v yau6rl
3 Jul 18
Correspondence with SEC
12:00am
20-F
8gr9o u5l9b0c4cw6v
1 May 17
Annual report (foreign)
12:00am
20-F
EX-4.3
k2n6o9ozlsyqrux sr
1 May 17
Annual report (foreign)
12:00am